The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors.

ABSTRACT:

SUBMITTER: Bronte G 

PROVIDER: S-EPMC10803613 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature